{
    "title": "Genome bid 'full and fair' insists Glaxo as it disappoints investors with first-quarter results",
    "url": "https://www.dailymail.co.uk/money/news/article-2135211/Genome-bid-fair-insists-Glaxo-disappoints-investors-quarter-results.html",
    "date": "2012-04-25",
    "keywords": [
        "hgs",
        "gsk",
        "cent",
        "share",
        "bid",
        "mail",
        "executive",
        "sir",
        "compelling",
        "option",
        "business",
        "pipeline",
        "dividend",
        "gmt",
        "april",
        "view",
        "glaxosmithkline",
        "offer",
        "partner",
        "genome",
        "control",
        "time",
        "value",
        "premium",
        "price",
        "half",
        "clutch",
        "end",
        "patent",
        "protection",
        "cutprice",
        "drug",
        "advair",
        "threat",
        "treatment",
        "lupus",
        "approval",
        "boss",
        "rise",
        "founder",
        "mike",
        "bonus",
        "worth",
        "operating",
        "government",
        "austerity",
        "europe",
        "track",
        "growth",
        "whole",
        "analyst",
        "year",
        "yield",
        "catalyst",
        "point"
    ],
    "category": [
        "money",
        "news"
    ]
}